HLA and narcolepsy-cataplexy in the Sardinian population

Journal of Sleep Research

Volumn 19, Issue 4, 2010, Pages 624-625

  Molari, Andrea ^a   Carcassi, Carlo ^b  

^a BROTZU HOSPITAL   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; OREXIN;

ANAMNESIS; BRAIN NERVE CELL; CATAPLEXY; CEREBROSPINAL FLUID; DAYTIME SOMNOLENCE; ETHNIC GROUP; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LETTER; MULTIPLE SCLEROSIS; NARCOLEPSY; POLYSOMNOGRAPHY; PREVALENCE; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; HLA-DQ ANTIGENS; HUMANS; ITALY; LINKAGE DISEQUILIBRIUM; NARCOLEPSY;

EID: 77958525434     PISSN: 09621105     EISSN: 13652869     Source Type: Journal    
DOI: 10.1111/j.1365-2869.2010.00849.x     Document Type: Letter

References (12)

1. American Academy of Sleep Medicine. The International Classification of Sleep Disorders: Diagnostic and Coding Manual, 2nd edn. American Academy of Sleep Medicine, Westchester, IL, 2005.
2. Fronczek, R., Baumann, C. R., Lammers, G. J., Bassetti, C. L. and Overeem, S. Hypocretin/orexin disturbances in neurological disorders. Sleep Med. Rev., 2009, 13: 9-22.
3. Imanishi, T., Akaza, T., Kimura, A., Tokunaga, K. and Gojobori, T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: K. Tsuji, M. Aizawa and T. Sasazuki (Eds) HLA 1991. Oxford University Press, Oxford, 1992: 1065-1220.
4. Kanbayashi, T., Inoue, Y., Chiba, S. et al. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J. Sleep Res., 2002, 11: 91-93.
5. Krahn, L. E., Pankratz, V. S., Oliver, L., Boeve, B. F. and Silber, M. H. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Sleep, 2002, 25: 733-736.
6. Kwon, O. J., Karni, A., Israel, S. et al. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch. Neurol., 1999, 56: 555-560.
7. Lampis, R., Morelli, L., De Virgiliis, S., Congia, M. and Cucca, F. The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations. Tissue Antigens, 2000, 56: 515-521.
8. Lavie, P. and Peled, R. Narcolepsy is a rare disease in Israel. Sleep, 1987, 10: 608-609.
9. Longstreth, W. T., Koepsell, T. D., Ton, T. G., Hendrickson, A. F. and Van Belle, G. The epidemiology of narcolepsy. Sleep, 2007, 30: 13-26.
10. Matsuki, K., Grumet, F.C., Lin, X. et al. DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet, 1992, 339: 1052.
11. Mignot, E., Lammers, G. J., Ripley, B. et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol., 2002, 59: 1553-1562.
12. Rogers, A. E., Meehan, J., Guilleminault, C., Grumet, F. C. and Mignot, E. HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy. Neurology, 1997, 48: 1550-1556.